Literature DB >> 26744322

Capecitabine-Induced Severe Toxicity Secondary to DPD Deficiency and Successful Treatment with Low Dose 5-Fluorouracil.

Saranya Kodali1, Venu Bathini2, Paul Rava3, Eswar Tipirneni4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 26744322     DOI： 10.1007/s12029-015-9797-x

Source DB:  PubMed          Journal:  J Gastrointest Cancer


× No keyword cloud information.
  15 in total

1.  Severe fluoropyrimidine-related toxicity: clinical implications of DPYD analysis and UH2/U ratio evaluation.

Authors:  E Giorgio; C Caroti; F Mattioli; V Uliana; M I Parodi; Mauro D'Amico; C Fucile; V Marini; F Forzano; G Cassola; A Martelli; F Faravelli; E Di Maria
Journal:  Cancer Chemother Pharmacol       Date:  2011-08-11       Impact factor: 3.333

2.  A well-tolerated 5-FU-based treatment subsequent to severe capecitabine-induced toxicity in a DPD-deficient patient.

Authors:  Hélène Blasco; Michéle Boisdron-Celle; Philippe Bougnoux; Gilles Calais; Jean-François Tournamille; Joseph Ciccolini; Elisabeth Autret-Leca; Chantal Le Guellec
Journal:  Br J Clin Pharmacol       Date:  2008-02-20       Impact factor: 4.335

Review 3.  A systematic review of raltitrexed-based first-line chemotherapy in advanced colorectal cancer.

Authors:  Sandro Barni; Antonio Ghidini; Andrea Coinu; Karen Borgonovo; Fausto Petrelli
Journal:  Anticancer Drugs       Date:  2014-11       Impact factor: 2.248

Review 4.  Profiling dihydropyrimidine dehydrogenase deficiency in patients with cancer undergoing 5-fluorouracil/capecitabine therapy.

Authors:  Cédric Mercier; Joseph Ciccolini
Journal:  Clin Colorectal Cancer       Date:  2006-11       Impact factor: 4.481

5.  A rapid and inexpensive method for anticipating severe toxicity to fluorouracil and fluorouracil-based chemotherapy.

Authors:  Joseph Ciccolini; Cédric Mercier; Alexandre Evrard; Laetitia Dahan; Jean-Christophe Boyer; Florence Duffaud; Karine Richard; Carmelo Blanquicett; Gérard Milano; Aurore Blesius; Alain Durand; Jean-François Seitz; Roger Favre; Bruno Lacarelle
Journal:  Ther Drug Monit       Date:  2006-10       Impact factor: 3.681

6.  Fluoropyrimidine toxicity in patients with dihydropyrimidine dehydrogenase splice site variant: the need for further revision of dose and schedule.

Authors:  Elena Magnani; Enrico Farnetti; Davide Nicoli; Bruno Casali; Luisa Savoldi; Chiara Focaccetti; Corrado Boni; Adriana Albini; Maria Banzi
Journal:  Intern Emerg Med       Date:  2013-04-13       Impact factor: 3.397

7.  Upfront Genotyping of DPYD*2A to Individualize Fluoropyrimidine Therapy: A Safety and Cost Analysis.

Authors:  Maarten J Deenen; Didier Meulendijks; Annemieke Cats; Marjolein K Sechterberger; Johan L Severens; Henk Boot; Paul H Smits; Hilde Rosing; Caroline M P W Mandigers; Marcel Soesan; Jos H Beijnen; Jan H M Schellens
Journal:  J Clin Oncol       Date:  2015-11-16       Impact factor: 44.544

Review 8.  Dihydropyrimidine dehydrogenase deficiency, a pharmacogenetic syndrome associated with potentially life-threatening toxicity following 5-fluorouracil administration.

Authors:  Hany Ezzeldin; Robert Diasio
Journal:  Clin Colorectal Cancer       Date:  2004-09       Impact factor: 4.481

9.  Clinical Pharmacogenetics Implementation Consortium guidelines for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing.

Authors:  K E Caudle; C F Thorn; T E Klein; J J Swen; H L McLeod; R B Diasio; M Schwab
Journal:  Clin Pharmacol Ther       Date:  2013-08-29       Impact factor: 6.875

10.  Pharmacokinetics of 5-fluorouracil in patients heterozygous for the IVS14+1G > A mutation in the dihydropyrimidine dehydrogenase gene.

Authors:  A B P van Kuilenburg; J G Maring; A Schalhorn; C Terborg; H Schmalenberg; D Behnke; W Schwabe; K Jabschinsky; P Hausler
Journal:  Nucleosides Nucleotides Nucleic Acids       Date:  2008-06       Impact factor: 1.381
View more
  1 in total

1.  Capecitabine-Induced Severe Toxicity Secondary to DPD Deficiency and Successful Treatment with Low Dose 5-Fluorouracil.

Authors:  Catc Lunenburg; J J Swen; H-J Guchelaar; H Gelderblom
Journal:  J Gastrointest Cancer       Date:  2017-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.